| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/ERM.09.21 |
| P698 | PubMed publication ID | 19580433 |
| P50 | author | Larisa Gubareva | Q66732793 |
| P2093 | author name string | Varough M Deyde | |
| P2860 | cites work | Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda | Q21090519 |
| DNA sequencing with chain-terminating inhibitors | Q22066207 | ||
| Genomic signatures of human versus avian influenza A viruses | Q24623524 | ||
| Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants | Q27650620 | ||
| Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase | Q27651719 | ||
| Serial analysis of gene expression | Q27860777 | ||
| Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis | Q28217446 | ||
| Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern | Q28275022 | ||
| A sequencing method based on real-time pyrophosphate | Q28279786 | ||
| Real-time DNA sequencing using detection of pyrophosphate release | Q28297219 | ||
| Mortality associated with influenza and respiratory syncytial virus in the United States | Q29615578 | ||
| Oseltamivir resistance during treatment of influenza A (H5N1) infection | Q29618722 | ||
| Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir | Q30306773 | ||
| Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay | Q30308218 | ||
| Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. | Q30350180 | ||
| Avian flu: isolation of drug-resistant H5N1 virus. | Q30351638 | ||
| Antiviral resistance in influenza viruses--implications for management and pandemic response. | Q30353085 | ||
| The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. | Q30356303 | ||
| Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir. | Q30356532 | ||
| Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase. | Q30370020 | ||
| Detection of human virulence signatures in H5N1. | Q30372770 | ||
| Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method. | Q30374227 | ||
| Recovery of drug-resistant influenza virus from immunocompromised patients: a case series | Q30439558 | ||
| Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. | Q30445738 | ||
| Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. | Q30452889 | ||
| Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. | Q30453005 | ||
| Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus | Q30472691 | ||
| Method enabling fast partial sequencing of cDNA clones | Q30989468 | ||
| Oral oseltamivir treatment of influenza in children. | Q32064242 | ||
| Gene expression analysis by signature pyrosequencing. | Q32120004 | ||
| Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. | Q33243576 | ||
| Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. | Q33263979 | ||
| Rapid and highly informative diagnostic assay for H5N1 influenza viruses | Q33267356 | ||
| Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir | Q33354941 | ||
| Reduced sensitivity of influenza A (H5N1) to oseltamivir | Q33800864 | ||
| Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors | Q33827578 | ||
| Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing | Q33971117 | ||
| Pyrosequencing as a method for grouping of Listeria monocytogenes strains on the basis of single-nucleotide polymorphisms in the inlB gene | Q33990764 | ||
| Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia. | Q34085472 | ||
| Position statement: global neuraminidase inhibitor susceptibility network | Q34294358 | ||
| Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors | Q34615286 | ||
| Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide | Q34637724 | ||
| Cold-adapted, live attenuated influenza vaccine | Q35728567 | ||
| Design and validation of an H5 TaqMan real-time one-step reverse transcription-PCR and confirmatory assays for diagnosis and verification of influenza A virus H5 infections in humans | Q35784623 | ||
| Pyrosequencing: history, biochemistry and future | Q36258365 | ||
| Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. | Q36870919 | ||
| Mutations of neuraminidase implicated in neuraminidase inhibitors resistance | Q37022596 | ||
| Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen | Q37099761 | ||
| Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations | Q37139125 | ||
| Discovery of single nucleotide polymorphisms and mutations by pyrosequencing | Q37217263 | ||
| Quantification of HIV-1 using multiple quantitative polymerase chain reaction standards and bioluminometric detection | Q38305219 | ||
| Pyrosequencing technology as a method for the diagnosis of multiple endocrine neoplasia type 2. | Q38449326 | ||
| Quantitation of site-specific HPV 16 DNA methylation by pyrosequencing | Q40219565 | ||
| Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations. | Q40467433 | ||
| Multiple group-specific sequencing primers for reliable and rapid DNA sequencing | Q40565788 | ||
| In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir | Q40911739 | ||
| Analysis of read length limiting factors in Pyrosequencing chemistry | Q42241550 | ||
| Novel virus discovery in field-collected mosquito larvae using an improved system for rapid determination of viral RNA sequences (RDV ver4.0). | Q42983948 | ||
| Determination of hepatitis C virus genotype by Pyrosequencing | Q43048804 | ||
| Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan | Q43209459 | ||
| Long-read pyrosequencing using pure 2'-deoxyadenosine-5'-O'-(1-thiotriphosphate) Sp-isomer | Q43866830 | ||
| Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes | Q43889383 | ||
| Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene | Q44159599 | ||
| Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencing. | Q44381031 | ||
| Assaying susceptibility of avian and other influenza A viruses to zanamivir: comparison of fluorescent and chemiluminescent neuraminidase assays | Q44629476 | ||
| HPV-related cancer susceptibility and p53 codon 72 polymorphism | Q44932099 | ||
| Resistant influenza A viruses in children treated with oseltamivir: descriptive study | Q45036693 | ||
| Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States | Q45118572 | ||
| Prolonged excretion of amantadine-resistant influenza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient | Q45733987 | ||
| A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1. | Q46412604 | ||
| Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses | Q46417983 | ||
| Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States | Q46925884 | ||
| Polymorphisms of the Fc gamma receptor type IIB gene are not associated with systemic lupus erythematosus in the Swedish population | Q47784160 | ||
| Multiple‐primer DNA sequencing method | Q47959538 | ||
| Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses. | Q53449602 | ||
| Both risk alleles for FcγRIIA and FcγRIIIA are susceptibility factors for SLE: a unifying hypothesis | Q57461989 | ||
| Structural biology: Antiviral drugs fit for a purpose | Q58979755 | ||
| P4510 | describes a project that uses | pyrosequencing | Q2342248 |
| P433 | issue | 5 | |
| P921 | main subject | pyrosequencing | Q2342248 |
| P304 | page(s) | 493-509 | |
| P577 | publication date | 2009-07-01 | |
| P1433 | published in | Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare | Q15756305 |
| P1476 | title | Influenza genome analysis using pyrosequencing method: current applications for a moving target | |
| P478 | volume | 9 |
| Q90671419 | A multiplex real-time PCR assay for detection of oseltamivir-resistant strains of influenza virus |
| Q35168895 | Application of a seven-target pyrosequencing assay to improve the detection of neuraminidase inhibitor-resistant Influenza A(H3N2) viruses |
| Q27013442 | Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors |
| Q30403699 | Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients |
| Q30399274 | Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance |
| Q38226696 | Deep sequencing: becoming a critical tool in clinical virology |
| Q30399501 | Detection of hemagglutinin variants of the pandemic influenza A (H1N1) 2009 virus by pyrosequencing |
| Q30383771 | Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. |
| Q34292717 | Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria |
| Q34910490 | Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010. |
| Q30396031 | Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir |
| Q39754099 | Fitting evolutionary process of influenza A virus nucleoproteins using analytical solution of system of differential equations |
| Q30391963 | Highly Sensitive and Quantitative Detection of the H274Y Oseltamivir Resistance Mutation in Seasonal A/H1N1 Influenza Virus |
| Q30396357 | Identification of oseltamivir resistance among pandemic and seasonal influenza A (H1N1) viruses by an His275Tyr genotyping assay using the cycling probe method |
| Q43143888 | Influenza virus surveillance by the Instituto Adolfo Lutz, influenza season 2014: antiviral resistance |
| Q45947329 | Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season. |
| Q42856186 | Pyrosequencing analysis for a rapid classification of fowl adenovirus species |
| Q42929558 | Rapid and specific detection of amantadine-resistant influenza A viruses with a Ser31Asn mutation by the cycling probe method |
| Q33952453 | Rapid detection of the H275Y oseltamivir resistance mutation in influenza A/H1N1 2009 by single base pair RT-PCR and high-resolution melting |
| Q30408167 | Reverse-transcription polymerase chain reaction/pyrosequencing to characterize neuraminidase H275 residue of influenza A 2009 H1N1 virus for rapid and specific detection of the viral oseltamivir resistance marker in a clinical laboratory |
| Q35058607 | Ultra-deep pyrosequencing of partial surface protein genes from infectious Salmon Anaemia virus (ISAV) suggest novel mechanisms involved in transition to virulence. |
Search more.